Swedish Oat Fiber is a leading producer of oat ingredients rich in beta-glucans.
DSM Nutritional Products (Parsippany, NJ) has acquired Swedish Oat Fiber (Bua, Sweden), a specialty producer of oat bran rich in beta-glucans. Swedish Oat Fiber will still produce its ingredients, but DSM will assume sales and marketing activities.
Beta-glucans have a favorable reputation among various health agencies, with EFSA and FDA offering their own health claims for beta-glucans. Available from multiple food sources, beta-glucans have been associated with potential for cholesterol reduction, blood glucose control, and gastrointestinal health.
Swedish Oat Fiber distributes its OatWell brand ingredients throughout North America under Oat Ingredients LLC (Boulder, CO).
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Judge in CRN’s complaint against NY denies the State’s motion to dismiss
Published: May 14th 2024 | Updated: May 15th 2024New York State's motion to dismiss CRN's lawsuit against the law banning the sale of weight management and muscle-building supplements to minors has been partially denied, allowing CRN to proceed with its First Amendment Claim.